|
|
|
Insider
Information: |
Catlin Avery W |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
97,936 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,522,699 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
97,936 |
|
|
Total
Value |
$2,522,699 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celldex Therapeutics Inc |
CLDX |
Sr. VP & CFO |
2016-09-02 |
83,586 |
2003-07-24 |
0 |
Premium* |
|
Corbus Pharmaceuticals Holdings,... |
CRBP |
|
2024-05-30 |
4,350 |
2015-06-09 |
0 |
Premium* |
|
Provention Bio Inc |
PRVB |
Director |
2023-04-13 |
10,000 |
2023-04-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRBP |
Corbus Pharmaceuticals Ho... |
|
|
2024-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
4,350 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Director |
|
2015-06-09 |
4 |
B |
$3.10 |
$62,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Director |
|
2015-08-17 |
4 |
B |
$1.90 |
$22,842 |
D/D |
11,788 |
31,788 |
2.39 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Director |
|
2015-08-18 |
4 |
B |
$1.90 |
$15,603 |
D/D |
8,212 |
40,000 |
2.39 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Director |
|
2016-11-22 |
4 |
B |
$7.55 |
$15,100 |
D/D |
2,000 |
42,000 |
2.39 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Director |
|
2017-05-11 |
4 |
B |
$6.15 |
$30,741 |
D/D |
5,000 |
47,000 |
2.39 |
- |
|
PRVB |
Provention Bio Inc |
Director |
|
2018-11-09 |
4 |
B |
$3.15 |
$31,500 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
PRVB |
Provention Bio Inc |
Director |
|
2018-12-24 |
4 |
B |
$1.90 |
$9,500 |
I/I |
5,000 |
15,000 |
2.1 |
- |
|
PRVB |
Provention Bio Inc |
Director |
|
2018-12-26 |
4 |
B |
$1.85 |
$9,250 |
I/I |
5,000 |
20,000 |
2.1 |
- |
|
PRVB |
Provention Bio Inc |
Director |
|
2023-04-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
PRVB |
Provention Bio Inc |
Director |
|
2023-04-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
PRVB |
Provention Bio Inc |
Director |
|
2023-04-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(20,000) |
0 |
0 |
- |
|
CLDX |
Celldex Therapeutics Inc |
officerTitle |
|
2003-07-24 |
4 |
A |
$0.97 |
$485 |
D/D |
500 |
6,000 |
|
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2004-07-01 |
4 |
A |
$2.26 |
$1,131 |
D/D |
500 |
6,500 |
|
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2004-08-03 |
4 |
B |
$1.83 |
$6,388 |
D/D |
3,500 |
10,000 |
2.74 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2005-07-01 |
4 |
A |
$0.99 |
$497 |
D/D |
500 |
10,500 |
|
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2005-11-22 |
4 |
OE |
$1.14 |
$5,700 |
D/D |
5,000 |
15,500 |
|
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2006-07-03 |
4 |
A |
$1.37 |
$685 |
D/D |
500 |
16,000 |
|
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2006-08-16 |
4 |
B |
$1.35 |
$6,750 |
D/D |
5,000 |
21,000 |
2.74 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2007-07-02 |
4 |
A |
$0.71 |
$353 |
D/D |
500 |
21,500 |
0 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2009-01-02 |
4 |
A |
$6.73 |
$673 |
D/D |
100 |
100 |
0 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
7,759 |
0 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2009-11-30 |
4 |
B |
$4.41 |
$4,408 |
D/D |
1,000 |
1,000 |
2.66 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2010-09-08 |
4 |
B |
$3.51 |
$7,016 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
CLDX |
Celldex Therapeutics Inc |
Sr. VP & CFO |
|
2011-08-09 |
4 |
B |
$2.39 |
$4,780 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
37 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|